NeoPrediX AG
PrivateLast Round
Early Funding
Sep 10, 2024
Total Funding Raised
$4.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeoPrediX AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was an Early Funding round in September 2024.
NeoPrediX AG is a health-tech company that develops clinical decision support software and predictive analytics platforms for maternal, neonatal, and perinatal care.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeoPrediX AG Comparables
Compare NeoPrediX AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NOMA AI | 84% | |
| Innocens BV | 84% | |
| riskLD | 82% |
For institutional investors. Book with your work email.
NeoPrediX AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 10, 2024 | ||||
| Series A | Mar 18, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeoPrediX AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeCare Partners | Series A |
| Springhood Ventures | Early Funding |
| Eckenstein-Geigy-Stiftung | Series A |
| Bayern Kapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 85% MoM.
- Oct 8, 2025
PreFree product launched across CE-marked markets.
For institutional investors. Book with your work email.
NeoPrediX AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeoPrediX AG's valuation, stock price, and market status.
Is NeoPrediX AG a public or private company?
NeoPrediX AG is a private company.
What is the current stock price of NeoPrediX AG?
NeoPrediX AG is a private company, so its shares have no public market price. Caplight tracks NeoPrediX AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeoPrediX AG worth (valuation)?
Valuation information for NeoPrediX AG is not publicly available.
Can I buy NeoPrediX AG stock?
NeoPrediX AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeoPrediX AG's last funding round?
NeoPrediX AG's most recent funding round was Early Funding on September 10, 2024.
Who are the main investors in NeoPrediX AG?
Key investors in NeoPrediX AG include LifeCare Partners, Springhood Ventures.
Will NeoPrediX AG IPO soon?
No public IPO plans have been announced for NeoPrediX AG.
How can I track NeoPrediX AG secondary market activity?
Caplight tracks bids, offers, and trades in NeoPrediX AG's shares on secondary markets.